Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time.

While Cathie Wood’s involvement adds visibility, market sentiment remains mixed on whether ALMR offers sustainable upside at ...

Proteomics is emerging as a promising approach for identifying autism biomarkers by detecting protein-level changes linked to ...

Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective ...

This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical ...

Spatial proteomics represents a revolutionary frontier in molecular biology, enabling researchers to explore protein expression while preserving the critical spatial context of tissue architecture.

This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...

Cathie Wood’s ARK Invest made a series of targeted portfolio adjustments across its active ETFs during the last week, though ...

RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of the Orion™ HT and Orion™ ...

Proteomics is the large-scale study of proteins, particularly their structures and functions. It involves the systematic identification, quantification, and analysis of the entire protein complement ...

A high-resolution proteomic landscape of minor glomerular abnormalities (MGAs) is established via pressure cycling technology ...

Recurrent Florida west coast blooms produce brevetoxins that bioaccumulate and aerosolize, causing neurologic toxicity in turtles through VGSC modulation and complicating temporally linked exposure ...